Allez à nos transactions
Soins de la Santé

Prevtec Microbia has raised an undisclosed amount

March 2014 — Prevtec Microbia has raised an undisclosed amount.

Prevtec Microbia is a Canadian biotechnology company specialized in the development of vaccines and other technologies that help fight against bacterial diseases in animal foods, improve animal health and increase animal production performance. It is an innovation-centric company that operates in many areas through strategic alliances around the world.

Our role in the transaction

Oaklins’ team in Montreal, Canada, advised Prevtec Microbia in the transaction.

Contacter l'équipe de la transaction

Fausto Levy

Chef de la direction
Montréal, Canada
Oaklins Canada

Transactions connexes

Life & Mobility has attracted investor Bolster Investment Partners
Placements Privés | Soins de la Santé

Life & Mobility has attracted investor Bolster Investment Partners

Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.  

En apprendre plus
Asana Gruppe has sold selected outpatient service areas to Luzerner Kantonsspital
Soins de la Santé

Asana Gruppe has sold selected outpatient service areas to Luzerner Kantonsspital

Luzerner Kantonsspital (LUKS) has acquired key parts of Asana Spital Menziken AG’s outpatient services from Asana Gruppe AG, including its ambulance service, primary care practice and ambulatory care center. The transaction supports the long-term continuity of local medical care in the Swiss Wynen and Seetal regions and ensures these services remain available close to patients’ homes.

En apprendre plus
Laboratoires Herbolistique has received a majority investment from Yotta Capital Partners and co-investors
Placements Privés | Soins de la Santé

Laboratoires Herbolistique has received a majority investment from Yotta Capital Partners and co-investors

Laboratoires Herbolistique has received a majority investment from Yotta Capital Partners alongside co-investors Ouest Croissance, Sodero and CE IDF, with Bpifrance, Océans Participations and the management team reinvesting.

En apprendre plus